RXRX logo

RXRX Stock Overview

Profile

Full Name:

Recursion Pharmaceuticals, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

April 16, 2021

Indexes:

Not included

Description:

Recursion Pharmaceuticals, or RXRX, uses advanced technology and artificial intelligence to discover new drugs. They focus on understanding diseases at a cellular level, aiming to develop treatments for various health conditions more efficiently and effectively than traditional methods. Their goal is to improve patient outcomes through innovative solutions.

Events Calendar

Earnings

Next earnings date:

Feb 27, 2025

Recent quarterly earnings:

Nov 6, 2024

Recent annual earnings:

Feb 27, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 6, 25 Needham
Buy
Jan 8, 25 Keybanc
Overweight
Dec 11, 24 Needham
Buy
Nov 20, 24 Needham
Buy
Nov 7, 24 Needham
Buy
Sep 4, 24 Needham
Buy
Sep 3, 24 Leerink Partners
Market Perform
Sep 3, 24 Jefferies
Hold
Aug 9, 24 Needham
Buy
Jul 11, 24 Keybanc
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Recursion Pharmaceuticals?
  • Does Recursion Pharmaceuticals pay dividends?
  • What sector is Recursion Pharmaceuticals in?
  • What industry is Recursion Pharmaceuticals in?
  • What country is Recursion Pharmaceuticals based in?
  • When did Recursion Pharmaceuticals go public?
  • Is Recursion Pharmaceuticals in the S&P 500?
  • Is Recursion Pharmaceuticals in the NASDAQ 100?
  • Is Recursion Pharmaceuticals in the Dow Jones?
  • When was Recursion Pharmaceuticals's last earnings report?
  • When does Recursion Pharmaceuticals report earnings?
  • Should I buy Recursion Pharmaceuticals stock now?

What is the ticker symbol for Recursion Pharmaceuticals?

The ticker symbol for Recursion Pharmaceuticals is NASDAQ:RXRX

Does Recursion Pharmaceuticals pay dividends?

No, Recursion Pharmaceuticals does not pay dividends

What sector is Recursion Pharmaceuticals in?

Recursion Pharmaceuticals is in the Healthcare sector

What industry is Recursion Pharmaceuticals in?

Recursion Pharmaceuticals is in the Biotechnology industry

What country is Recursion Pharmaceuticals based in?

Recursion Pharmaceuticals is headquartered in United States

When did Recursion Pharmaceuticals go public?

Recursion Pharmaceuticals's initial public offering (IPO) was on April 16, 2021

Is Recursion Pharmaceuticals in the S&P 500?

No, Recursion Pharmaceuticals is not included in the S&P 500 index

Is Recursion Pharmaceuticals in the NASDAQ 100?

No, Recursion Pharmaceuticals is not included in the NASDAQ 100 index

Is Recursion Pharmaceuticals in the Dow Jones?

No, Recursion Pharmaceuticals is not included in the Dow Jones index

When was Recursion Pharmaceuticals's last earnings report?

Recursion Pharmaceuticals's most recent earnings report was on Nov 6, 2024

When does Recursion Pharmaceuticals report earnings?

The next expected earnings date for Recursion Pharmaceuticals is Feb 27, 2025

Should I buy Recursion Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions